724
Participants
Start Date
July 31, 2005
Primary Completion Date
September 30, 2006
Study Completion Date
July 31, 2014
dasatinib
Tablets, Oral, 50 mg BID, indefinitely, survival study
dasatinib
Tablets, Oral, 70 mg BID, indefinitely, survival study
dasatinib
Tablets, Oral, 100 mg QD, indefinitely, survival study
dasatinib
Tablets, Oral, 140 mg QD, indefinitely, survival study
Local Institution, Dublin
Local Institution, Jesus Maria
Local Institution, Lima
Local Institution, Taipei
Local Institution, Taoyuan
Local Institution, Brussels
Local Institution, Vienna
Local Institution, Quezon City
Local Institution, Budapest
Local Institution, Buenos Aires
Local Institution, Capital Federal
Local Institution, La Plata
Local Institution, Soweto
Local Institution, Camperdown
Local Institution, St Leonards
Local Institution, Parktown
Local Institution, Edegem
Local Institution, Herlev
Local Institution, B-leuven
Local Institution, East Melbourne
Local Institution, Basel
Local Institution, South Brisbane
Local Institution, Odense C
Local Institution, Yvoir
Local Institution, Charleroi
Local Institution, Trondheim
Local Institution, Observatory
Local Institution, Bruges
Local Institution, Aarhus C
Local Institution, Bloemfontein
New York Presbyterian Hospital, New York
Local Institution, Orbassano
Local Institution, CEP - Campinas
Local Institution, Marseille
Local Institution, Caen
Western Pennsylvania Cancer Institute, Pittsburgh
Georgetown University Med Ctr, Washington D.C.
Washington Cancer Institute At Washington Hospital Center, Washington D.C.
Local Institution, Monza (mi)
Local Institution, Rio de Janeiro
Local Institution, Hamburg
University Of Maryland, Baltimore
Local Institution, Lund
University Of North Carolina At Chapel Hill, Chapel Hill
Local Institution, Madrid
Local Institution, Madrid
Gwinnett Hospital System Inc., Lawrenceville
Emory University School Of Medicine, Atlanta
Georgia Cancer Specialists, Atlanta
Local Institution, Pamplona
Local Institution, Toulouse
Local Institution, Krakow
University Of Florida, Gainesville
Md Anderson Cancer Center Orlando, Orlando
University Of Miami, Miami
University Of Alabama At Birmingham, Birmingham
Sarah Cannon Research Institute, Nashville
Local Institution, Grenoble
Local Institution, Katowice
University Of Kentucky, Lexington
Local Institution, Nantes
Cleveland Clinic Foundation, Cleveland
Indiana University Cancer Center, Indianapolis
Karmanos Cancer Institute, Detroit
Local Institution, Ramat Gan
Local Institution, Mainz
Local Institution, Lille
Local Institution, Frankfurt am Main
Northwestern University Feinberg School Of Medicine, Chicago
University Of Chicago, Chicago
Oncology Hematology Associates Of Central Illinois, Pc, Peoria
Washington University School Of Medicine, St Louis
University Of Kansas Medical Center, Westwood
Local Institution, Strasbourg
Nebraska Methodist Hospital, Omaha
Local Institution, Mannheim
Devetten, Marcel, Omaha
Local Institution, Cedex
Local Institution, Bari
Ut Southwestern Medical Center, Dallas
Local Institution, Paris
The University Of Texas Md Anderson Cancer Center, Houston
Local Institution, Curitiba
Local Institution, Napoli
Local Institution, Poitiers
Nevada Cancer Institute, Las Vegas
Ucla Dept. Of Medicine, Los Angeles
Pacific Shores Medical Group, Long Beach
Central Hematology Oncology Medical Group Inc., Alhambra
Loma Linda University Cancer Center, Loma Linda
Pacific Cancer Medical Center Inc, Anaheim
Ventura County Hematology-Oncology Specialists, Oxnard
Local Institution, Lodz
Local Institution, Créteil
Kaiser Permanente Medical Center, Vallejo
Oregon Health & Science University, Portland
Seattle Cancer Care Alliance, Seattle
Local Institution, Moscow
Local Institution, Singapore
Local Institution, Saint Petersburg
Dana Faber Cancer Institute, Boston
The Cancer Center At Hackensack University Medical Center, Hackensack
The Cancer Institute Of New Jersey, New Brunswick
Local Institution, Córdoba
Local Institution, Adelaide
Local Institution, Perth
Local Institution, São Paulo
Local Institution, San Paulo, Sp
Local Institution, Edmonton
Local Institution, Hamilton
Local Institution, Montreal
Local Institution, Brno
Local Institution, Prague
Local Institution, Helsinki
Local Institution, Dresden
Local Institution, Leipzig
Local Institution, Co Galway
Local Institution, Roma
Local Institution, Roma
Local Institution, Distrito Federal
Local Institution, Nijmegen
Local Institution, Rotterdam
Local Institution, Gdansk
Local Institution, Lublin
Local Institution, Warsaw
Local Institution, Groenkloof
Local Institution, Jeollanam-do
Local Institution, Kyunggi-do
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Uppsala
Local Institution, Cambridge
Local Institution, London
Local Institution, Liverpool
Local Institution, Newcastle
Local Institution, Birmingham
Local Institution, Glasgow
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY